Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
β
of holders' portfolios
13F filers
1
institution
Market cap
$13.2B
112M shares
52-week range
$81.22 β $118.34
96% from low
Sector
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NYSE
CS
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
www.revvity.comNo one on the platform currently holds RVTY.
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 37,064 | $3.2M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-10-23 | $0.0700 | 2026-11-13 |
| 2026-07-17 | $0.0700 | 2026-08-07 |
| 2026-04-17 | $0.0700 | 2026-05-08 |
| 2026-01-16 | $0.0700 | 2026-02-06 |
| 2025-10-17 | $0.0700 | 2025-11-07 |
| 2025-07-18 | $0.0700 | 2025-08-08 |
| 2025-04-17 | $0.0700 | 2025-05-09 |
| 2025-01-17 | $0.0700 | 2025-02-07 |
| 2024-10-18 | $0.0700 | 2024-11-08 |
| 2024-07-19 | $0.0700 | 2024-08-09 |
No one on the platform has traded RVTY yet.
| 2024-04-18 | $0.0700 | 2024-05-10 |
| 2024-01-18 | $0.0700 | 2024-02-09 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
https://www.marketbeat.com/earnings/reports/2026-8-4-revvity-inc-stock/ $RVTY Revvity Earnings Transcript
View on StockTwits β$RVTY Q2 '26 Earnings Results & Recap β’ Reported GAAP EPS of $0.47 up 2.17% YoY β’ Reported revenue of $729.69M up 1.31% YoY β’ For the full year 2026, Revvity, Inc. forecasts total revenue of $2.83-$2.86 billion, pro forma organic revenue growth of 4-5%, and pro forma adjusted earnings per share of $5.30-$5.40.
View on StockTwits β$RVTY Bernstein has altered their rating of "Mkt Perform" and target of "$115" see consensus outlook
View on StockTwits β$RVTY Current Stock Price: $113.06 Contracts to trade: $115.0 RVTY Jul 17 2026 Call Entry: $3.00 Exit: $4.59 ROI: 53% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits β@No_Face_character @WAJeff @Jblack500 @cynicaloptimist @IsabellaDC @BustaCapital $RVTY +4.56
View on StockTwits β$RVTY Bought some of this and $AKRE.X (the ETF, not the token). Crazy volume today.
View on StockTwits β$RVTY continues to show a strong long-term bullish #ElliottWave structure π The bigger cycle remains supportive for further upside as buyers stay in control. Read more: https://elliottwave-forecast.com/stock-market/rvty-long-term-elliott-wave-analysis/ #Stocks #Trading #RVTY
View on StockTwits β$RVTY Something is going on here already traded 500K shares 15 min into trading
View on StockTwits β$RVTY CEO is stealing your $$β¦heβs mining $4M per year w a stock at a 5 year low β¦. Why would anyone invest 1 penny in this trash ?
View on StockTwits β$RVTY Just noticed there were 16 insider transactions on May 7 .. STOCK AWARDSβ¦ The stock is at a 5 year lowβ¦.lol It just gets worse and worseβ¦. I have to sell this β¦.this goes against all my convictions First an ESG guy goes to a health care conference and starts talking strategy which BTW was diff to what was discussed on the ER call Stocks donβt trade at 5 year lows for nothing β¦.
View on StockTwits βRecent $TICKER stream from stocktwits.com β refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.9B | +0.1% | $5.36 | $5.30β$5.43 | 21.8Γ | 7 |
| 2027 | $3.0B | +5.4% | $5.91 | $5.85β$6.00 | 19.8Γ | 8 |
| 2028 | $3.2B | +6.1% | $6.48 | $4.71β$9.00 | 18.0Γ | 3 |
| 2029 | $3.4B | +5.8% | $7.03 | $6.93β$7.21 | 16.6Γ | 1 |
Forward consensus Β· growth is YoY vs the prior fiscal-year estimate Β· Fwd P/E at the current price Β· source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $1.21 | $1.41 | +16.5% |
| 2026-05-05 | $1.02 | $1.06 | +3.9% |
| 2026-02-02 | $1.57 | $1.70 | +8.3% |
| 2025-10-27 | $1.14 | $1.18 | +3.5% |
| 2025-07-28 | $1.14 | $1.18 | +3.5% |
| 2025-04-28 | $0.96 | $1.01 | +5.2% |
| 2025-01-31 | $1.37 | $1.42 | +3.6% |
| 2024-11-04 | $1.13 |
| $1.28 |
| +13.3% |
| +0.00% |
| $20.0B |
| β |
| GHGuardant Health, Inc. | $157.21 | -1.46% | $21.1B | β |
| HIMSHims & Hers Health, Inc. | $28.15 | -2.16% | $6.3B | β |
Source: Financial Modeling Prep Β· peers by sector/industry